Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation

FHS
March 12, 2024
10:49 am

Exploristics’ cloud-based simulation platform KerusCloud used to enhance study design for Exonate’s upcoming Phase IIb study following successful Phase Ib/IIa study.

Broad-spectrum antibiotics linked to higher sepsis risk in neonates

A preprint presents evidence for the hypothesis that neonatal sepsis is linked to prenatal antibiotics.

September 7, 2023

Uncapping Capacity: Solving for Technology Overload in Clinical Trials

Melissa Easy, VP & General Manager of Clinical Technologies, IQVIA The clinical trial landscape has greatly benefited from technological innovations over the past few decades.

July 10, 2024

Why Cybin Could See Greater Opportunities After MAPS 2023

[embedded content] We’ve been enjoying our time on location at the MAPS Psychedelics Science Conference, and in our latest Trade to Black we are back

June 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.